# 心脉医疗 to acquire remaining 72.37% stake in OMD for $65M

心脉医疗's subsidiary MICROPORT ENDOVASTEC B.V. will acquire the remaining 72.37% stake in Optimum Medical Device Inc. (OMD) for $65 million, making OMD a wholly owned subsidiary. OMD holds Lombard Medical, which makes aortic stent graft products.

- Type: Acquisition
- Announced: 2024-07-01
- Value: $65.0M
- Status: announced
- Products: aortic stent graft systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lombard Medical](https://endata.com/companies/20848.md) (target)
- [Optimum Medical Device Inc.](https://endata.com/companies/78345.md) (target)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/1143963.html), 2024-07-01: "通过本次交易，OMD将成为公司的全资子公司，有利于加强公司在主动脉介入医疗器械研发、生产、销售等领域的协同"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.